jump to content jump to footer
Research poster presentation on standardized tumor response assessments using mint Lesion at the NCCN Annual Conference 2026

NCCN 2026: Memorial Sloan Kettering Cancer Center Presents Research on Structured Tumor Response Assessments with mint Lesion

Big congratulations to Steven Philemond and Alison Chiaramonte of Memorial Sloan Kettering Cancer Center for presenting their research poster “Use of Electronic Solution Supplemented with Portfolio of Tailored Resources Improves Tumor Response Assessment for Patients” at the recent 2026 NCCN Annual Conference.

Their work dives into how their institutional investment into standardizing clinical trial response assessments leveraging mint Lesion has improved operational efficiency and data quality in real, measurable ways since implementation in 2019:

  • 32% reduction in data deficiencies found during internal audits
  • Principal Investigator use increased from 10% (2019) to 78% (2024)
  • Integration with existing clinical research workflows enhanced inter-disciplinary collaboration

Benefits/Outcomes

Data Integrity

  • Quality: Automated calculations
  • Completeness: Fields of information required before sign-offs
  • Record-keeping: Legibility, timestamps
  • Privacy: Access granted to assessments by administrators
  • Reduction in deficiencies found by internal quality assurance audits

Reduce Administrative Burden

  • Automated back-end processes, such as automatically sending assessments to Epic EMR
  • Radiologist, Investigator, and Study Team user groups avoid using manual methods and sending them around for input and sign-offs
  • Share data with trial sponsors more readily

Ease of Use

  • Define a clear workflow among stakeholders to complete assessments
  • Tumor Response Assessments are housed in one location to improve accessibility for clinical staff and audit preparedness
  • Scalable to accommodate increase in assessment volume as well as new protocol criteria and  unique protocol structures

Financial

  • Bill more accurately for assessments
  • An assessment is never 'lost' and has to be redone

Read the full poster by clicking here.

Mint Medical is proud to support Memorial Sloan Kettering Cancer Centers's mission of ending cancer for life and can't wait to see what they accomplish next.

 If you're looking to transform the intersection of clinical imaging data in cancer research and how Mint Lesion can support your research aspirations, let's talk.

 

 

Success Story mintLesion Clinical Trials Standardized Reading Procedures Data Analysis Therapy Response Assessment Structured Reporting

Related Resources

Screenshot of the mint Lesion interface showing RANO 2.0 configuration, tumor burden calculations, and structured neuro-oncology assessment tools.
mint Lesion fully supports RANO 2.0 implementation with configurable parameters, automated tumor burden calculations, and structured workflows for neuro-oncology clinical trials.
Implementing RANO 2.0 for Neuro-Oncology Clinical Trials in mint Lesion
Tumor response assessment in neuro-oncology clinical trials requires careful attention to measurement protocols and confirmation scan requirements. To…
Image of a patient getting an MRI scan, signifying how RACOON projects in Germany show how imaging, structured reporting, and AI jointly advance clinical research.
Overview of major RACOON projects in radiology and clinical research.
RACOON – Imaging, Data & Collaboration for Better Decisions
Modern radiology faces a central question: how can imaging and clinical data be combined in a way that leads to more precise diagnoses,…
Interview with Prof. Timm Denecke about the RACOON-MARDER project and AI-powered early detection of liver cancer using MRI
An in-depth interview with Prof. Timm Denecke about the RACOON-MARDER project
Rethinking Early Detection: How RACOON-MARDER Aims to Spot Liver Cancer Sooner
Hepatocellular carcinoma (HCC) is often diagnosed too late, limiting treatment options and survival. The RACOON-MARDER project aims to change that. By…